BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sapisochin G, Sevilla EF, Echeverri J, Charco R. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World J Hepatol 2014; 6(11): 766-775 [PMID: 25429314 DOI: 10.4254/wjh.v6.i11.766]
URL: https://www.wjgnet.com/1007-9327/full/v6/i11/766.htm
Number Citing Articles
1
Fei Xue, Yuntian Liang, Zhenrong Li, Yanhui Liu, Hongwei Zhang, Yu Wen, Lei Yan, Qiang Tang, Erhui Xiao, Dongyi Zhang. MicroRNA‑9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A‑2Oncology Letters 2017;  doi: 10.3892/ol.2017.7399
2
Hye‐Lin Kim, Jihyun An, Jae‐A Park, Seung‐Hoo Park, Young‐Suk Lim, Eui‐Kyung Lee. Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With CirrhosisHepatology 2019; 69(4): 1599 doi: 10.1002/hep.30330
3
Panpan Li, Juanjuan Zhang, Fuchun Li, Yanyan Yu, Yinghong Chen. Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axisInternational Journal of Molecular Medicine 2019;  doi: 10.3892/ijmm.2019.4205
4
Gonzalo Sapisochín, Elena Fernández de Sevilla, Juan Echeverri, Ramón Charco. Liver transplantation for cholangiocarcinoma: Current status and new insightsWorld Journal of Hepatology 2015; 7(22): 2396-2403 doi: 10.4254/wjh.v7.i22.2396
5
Chen-Dan Zou, Wei-Ming Zhao, Xiao-Na Wang, Qiang Li, Hui Huang, Wan-Peng Cheng, Jian-Feng Jin, He Zhang, Ming-Juan Wu, Sheng Tai, Chao-Xia Zou, Xu Gao. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinomaOncotarget 2016; 7(1): 266 doi: 10.18632/oncotarget.5689
6
Wenzhe Si, Yang Zhao, Jiansuo Zhou, Qiang Zhang, Yuan Zhang. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101Experimental Cell Research 2019; 379(1): 1 doi: 10.1016/j.yexcr.2019.03.017
7
Tian’an Jiang, Linya Yu, Yilei Zhao, Baohua Wang. Artificial Liver2021; : 243 doi: 10.1007/978-981-15-5984-6_9
8
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, Shahid A. Khan, Alex Loukas, Alphonse E. Sirica, Bin Tean Teh, Sopit Wongkham, Gregory J. Gores. CholangiocarcinomaNature Reviews Disease Primers 2021; 7(1) doi: 10.1038/s41572-021-00300-2
9
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinomaThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
10
Hongyan Fan, Chenggang Zhou, Jianzhou Yan, Weihua Meng, Wenquan Zhang. Treatment of solitary hepatocellular carcinoma up to 2 cmMedicine 2020; 99(23): e20321 doi: 10.1097/MD.0000000000020321
11
Qiushuang Xiong, Shaoshuai Wu, Jingwen Wang, Xianhuang Zeng, Jianwen Chen, Mingcong Wei, Haotong Guan, Chengpeng Fan, Lang Chen, Deyin Guo, Guihong Sun. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpressionCell & Bioscience 2017; 7(1) doi: 10.1186/s13578-017-0144-8
12
Guoliang Wang, Wei Zhang, Yifei Tan, Li Jiang, Jian Yang, Jiayin Yang, Lunan Yan. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infectionInternational Journal of Surgery 2019; 72: 1 doi: 10.1016/j.ijsu.2019.10.006